KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$0.35.

  • Biogen's EPS (Weighted Average and Diluted) fell 11912.57% to -$0.35 in Q4 2025 from the same period last year, while for Dec 2025 it was $8.79, marking a year-over-year decrease of 2144.77%. This contributed to the annual value of $8.79 for FY2025, which is 2137.75% down from last year.
  • Per Biogen's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.35 for Q4 2025, which was down 11912.57% from $3.17 recorded in Q3 2025.
  • Over the past 5 years, Biogen's EPS (Weighted Average and Diluted) peaked at $7.84 during Q3 2022, and registered a low of -$0.68 during Q4 2021.
  • Its 5-year average for EPS (Weighted Average and Diluted) is $2.81, with a median of $2.68 in 2023.
  • Per our database at Business Quant, Biogen's EPS (Weighted Average and Diluted) plummeted by 13099.32% in 2021 and then skyrocketed by 66595.74% in 2024.
  • Biogen's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.68 in 2021, then skyrocketed by 663.21% to $3.83 in 2022, then plummeted by 55.34% to $1.71 in 2023, then increased by 7.02% to $1.83 in 2024, then tumbled by 119.13% to -$0.35 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.35 in Q4 2025, compared to $3.17 in Q3 2025 and $4.33 in Q2 2025.